Introducing Covid-19 as an Evolutionary Metabolic Infecious Disease (EMID): The Prime Cause and Representing Alternative Treatment for COVID-19 (SARS-CoV-2)

Authors: Niknamian S*

DOI: 10.23880/oajmms-16000127

Volume 3, Issue 2

Abstract

Background: Coronaviruses are a group of related viruses that cause diseases in mammals and birds. In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal. Mild illnesses include some cases of the common cold, while more lethal varieties can cause SARS, MERS, and COVID-19. The outbreak was identified in Wuhan, China, in December 2019, declared to be a Public Health Emergency of International Concern on 30 January 2020, and recognized as a pandemic on 11 March 2020. Introduction: Coronaviruses are the subfamily Orthocoronavirinae, within the family of Coronaviridae; order Nidovirales, and realm Riboviria. They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry. The genome size of coronaviruses is approximately from 26 to 32kilobases. Coronaviruses were first discovered in the 1930s and Human coronaviruses were discovered in the 1960s. The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43. Other human coronaviruses have since been identified, including SARS-CoV in 2003, HCoV NL63 in 2004, HKU1 in 2005, MERS-CoV in 2012, and SARS-CoV-2 in 2019. Most of these have involved serious respiratory tract infections.

Keywords: COVID-19; Mitochondria; Cyclotron; Resonance; Frequency; MMP; Royal Raymond Rife Protocol; Ultrasound Energy; LFMF; ELF-EMF; Immunodeficiency; Immune Response; Protein Mismatch in COVID-19

View PDF